Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Tools Improve Imaging of Cardiac Tissue and Vessels for Earlier Disease Diagnoses

By LabMedica International staff writers
Posted on 02 Jun 2025

Imaging cardiac diseases remains a major challenge due to the structural complexity and natural fluorescence of heart tissues, which often distorts images and hinders accurate diagnoses. More...

Traditional imaging techniques often fall short when it comes to observing small structures or fast changes in biological systems, especially within the heart. Many of them are limited by camera frame rates, data processing capacity, or poor visibility in deep tissue. Now, researchers have developed a powerful new algorithm that enhances cardiac imaging clarity, potentially allowing earlier and more precise detection of cardiovascular disease, the leading cause of death in the U.S.

Researchers at Georgia Institute of Technology (Atlanta, GA, USA), backed by the U.S. National Science Foundation (Alexandria, VA, USA), have introduced a tool that uses a technique called multiscale recursive decomposition to break down and analyze cardiovascular images more effectively. This method allows for high-resolution, multi-parameter visualization of cardiac activity — offering detailed views of heart chambers, blood vessels, and other dynamic signals without the typical limitations of current imaging tools. The new algorithm isolates and amplifies key biological signals from noisy or overlapping images, enabling real-time tracking of multiple cardiac functions simultaneously.

The tool also works with existing microscope setups, which could accelerate its adoption in both research and clinical settings. Detailed in Nature Cardiovascular Research, the algorithm has broad potential applications beyond heart imaging. It could improve live-cell imaging across other areas, such as brain research, and help scientists monitor biological processes at unprecedented detail, enhancing understanding of both disease progression and cellular behavior.

“Enhancing visualization of cardiac systems is just one application of this new tool,” said Eric Lyons, program director in the NSF Directorate for Biological Sciences. “This could also help advance live-cell imaging in other parts of the body, like the brain, and drive insights into fundamental biological processes and systems.”


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
All-in-One Molecular System
AIO M160
New
Repetitive Pipette
VWR® Stepper Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Plasma pTau217 testing can predict future amyloid accumulation and cognitive decline in cognitively healthy older adults (photo courtesy of Shutterstock)

Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read more

Industry

view channel
Image: The GenoPredict assay from Predicta Biosciences is available to Tempus Life Sciences partners to support exploratory research and clinical development programs (photo courtesy of Shutterstock)

Partnership Expands Ultrasensitive WGS Assay for for Hematologic Malignancies and MRD Monitoring

Tempus AI and Predicta Biosciences announced the commercial expansion of a co-branded whole‑genome sequencing assay GenoPredicta, which is intended for comprehensive genomic characterization of hematologic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.